PROFARMA DISTRIBUIDORA DE PRODUTOS FARMACÊUTICOS S.A. Profarma Distribuidora de Produtos Farmacêuticos S.A. Share Price
Equities
PFRM3
BRPFRMACNOR1
Drug Retailers
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.93 BRL | +0.17% |
|
+3.31% | -2.79% |
| Sales 2022 | 7.82B 1.53B 127B | Sales 2023 | 8.66B 1.69B 141B | Capitalization | 748M 146M 12.19B |
|---|---|---|---|---|---|
| Net income 2022 | 80M 15.64M 1.3B | Net income 2023 | 70M 13.69M 1.14B | EV / Sales 2022 | 0.17 x |
| Net Debt 2022 | 841M 164M 13.71B | Net Debt 2023 | 950M 186M 15.49B | EV / Sales 2023 | 0.2 x |
| P/E ratio 2022 |
5.56
x | P/E ratio 2023 |
10.6
x | Employees | 7,077 |
| Yield 2022 |
4.72% | Yield 2023 |
1.9% | Free-Float | 32.86% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +0.17% | ||
| 1 week | +3.31% | ||
| Current month | +2.42% | ||
| 1 month | +8.61% | ||
| 3 months | +24.58% | ||
| 6 months | +69.43% | ||
| Current year | -2.79% |
1 week
5.72
6.33
1 month
5.126.33
Current year
4.416.33
1 year
3.086.33
3 years
2.927.20
5 years
2.878.03
10 years
2.8722.38
| Managers | Title | Age | Since |
|---|---|---|---|
Sammy Birmarcker
CEO | Chief Executive Officer | 55 | 01/86/01 |
| Director of Finance/CFO | 65 | 01/93/01 | |
| Chief Operating Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Sammy Birmarcker
CEO | Chief Executive Officer | 55 | 01/86/01 |
| Founder | 89 | 01/61/01 | |
Carlos Gros
BRD | Director/Board Member | - | 10/20/10 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 117 M€ | +1.11% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/24/26 | 5.93 | -0.34% | 376,600 |
| 25/24/25 | 5.95 | -5.10% | 310,800 |
| 24/24/24 | 6.27 | +2.79% | 422,700 |
| 23/24/23 | 6.1 | +3.04% | 709,700 |
| 22/24/22 | 5.92 | +3.14% | 595,200 |
Delayed Quote Sao Paulo, April 27, 2024 at 01:37 am IST
More quotes
Profarma Distribuidora de Produtos Farmaceuticos SA is a Brazil-based company primarily engaged in the wholesale trading of drugs. The Company's activities are divided into two segments: Pharmaceutical Distribution and Retail. The Pharmaceutical Distribution division is responsible for the wholesale of medicines and personal care and beauty products to pharmaceutical retailers. The Retail division focuses on the management of a pharmacies network under a number of brand names, such as Drogasmil and Tamoio. Its products range includes prescription drugs, over-the-counter (OTC) generics, personal hygiene articles and cosmetics, vaccines, dermatological products and hospital pharmaceuticals, among others. The Company's subsidiaries include Farmadacta Informatica Ltda, Promovendas Representacoes Ltda, Interagile Propaganda e Promocoes Ltda and Locafarma Solucoes de Transportes e Logistica Ltda, among others.
Sector
Drug Retailers
Calendar
08/05/2024
- Q1 2024 Earnings Release
| 1st Jan change | Capi. | |
|---|---|---|
| -2.79% | 142M | |
| -32.21% | 15.27B | |
| -31.97% | 10.84B | |
| -30.42% | 6.06B | |
| +8.14% | 6.04B | |
| -11.41% | 5.86B | |
| -0.88% | 4.71B | |
| +52.19% | 4.29B | |
| -12.31% | 3.61B | |
| -14.86% | 3.33B |
- Stock Market
- Equities
- PFRM3 Stock
